Viewing Study NCT04544995


Ignite Creation Date: 2025-12-24 @ 2:00 PM
Ignite Modification Date: 2026-02-13 @ 4:51 PM
Study NCT ID: NCT04544995
Status: TERMINATED
Last Update Posted: 2025-07-16
First Post: 2020-09-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 213406
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators